ISSUES RAISED BY HUMAN CLONING RESEARCH
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Washington, DC: U.S. Government Printing Office [GPO], 2001. 153 p.
Showing items related by title, author, creator and subject.
Mutual Recognition Agreement: Food and Drug Administration's Progress in Assessing Equivalency of European Union Pharmaceutical Inspection Programs Letter From William J. Scanlon, Director, Health Financing and Public Health Issues to Rep. Thomas Bliley, Jr. and Rep. John D. Dingell on the U.S. Congress, House, Committee on Commerce and Rep. Fred Upton and Rep. Ron Klink on the U.S. Congress, House, Committee on Commerce, Subcommittee on Oversight and Investigations Scanlon, William J. (United States. General Accounting Office [GAO]. Health, Education and Human Services Division, 1999-02-26)
Blood Supply: Availability of Blood Statement of Janet Heinrich, Associate Director, Health Financing and Public Health Issues, Health, Education, and Human Services Division, Department of Health and Human Services, Before the Subcommittee On Oversight and Investigations, Committee on Commerce, US House of Representatives Heinrich, Janet (1999-09-23)
DIRECT-TO-CONSUMER GENETIC TESTS: MISLEADING TEST RESULTS ARE FURTHER COMPLICATED BY DECEPTIVE MARKETING AND OTHER QUESTIONABLE PRACTICES: TESTIMONY BEFORE THE SUBCOMMITTEE ON OVERSIGHT AND INVESTIGATIONS, COMMITTEE ON ENERGY AND COMMERCE, HOUSE OF REPRESENTATIVES United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations [and] United States. Government Accountability Office (2010)